Luncheon seminar at the 43rd Workshop of the Korean Society of Nonclinical Study
Join us for our luncheon seminar and visit us at booth #8 during the 43rd Workshop of...
Interview with Ikeura, President and CEO of Axcelead, a holding company, was published in “PHARMA JAPAN”. 『Axcelead to Expand Overseas Biz, Shoots for 130 Billion Yen Sales and 5,000-Plus Researchers』
As a global CRDMO (Contract Research, Development and Manufacturing Organization), Axelead, a holding company, will be fully...
Change of President & CEO
Kanagawa, Japan, April 13, 2023 — We announced that it has decided to make the following changes...
Orizuru Therapeutics and Axcelead DDP Collaborate on Drug Discovery Support Services Regarding iPS Cells
Kyoto and Kanagawa, Japan, March 10, 2023 — Orizuru Therapeutics Inc. (“OZTx”) and Axcelead Drug Discovery Partners,...
Teijin and Axcelead to Establish Drug Discovery Research JV
Tokyo, Japan, February 20, 2023 — Teijin Limited and Axcelead, Inc. jointly announced today their basic agreement...
Axcelead DDP Selected as Project Partner for Harvard Business School Immersive Field Course
Axcelead Drug Discovery Partners Inc. (Head Office: Fujisawa, Kanagawa prefecture, CEO: Yoshinori Ikeura, “Axcelead DDP”) was...